impact factor, citescore
logo
 

Letters to the Editor

 

Progression of large-vessel giant cell arteritis despite tocilizumab treatment


1, 2, 3, 4

 

  1. Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. elfishawi.mohanad@mayo.edu
  2. Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  3. Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  4. Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

CER15676
2023 Vol.41, N°4
PI 0985, PF 0986
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 35930482 [PubMed]

Received: 13/03/2022
Accepted : 24/06/2022
In Press: 03/08/2022
Published: 18/04/2023

Rheumatology Article